Gadolinium can depict area at risk and myocardial infarction: A double-edged sword?

JACC: Cardiovascular Imaging

Volumn 4, Issue 6, 2011, Pages 619-621

  Arai, Andrew E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

acute myocardial infarction; area at risk; CMR; edema; gadolinium

Indexed keywords

GADOLINIUM;

CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; EDITORIAL; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; PRIORITY JOURNAL;

CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS;

EID: 79958801918     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.04.006     Document Type: Editorial

References (23)

1. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992 2002.
2. Matsumoto H, Matsuda T, Miyamoto K, Shimada T, Mikuri M, Hiraoka Y. Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction. J Am Coll Cardiol Img 2011;4:610-8.
3. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-42. (Pubitemid 33126660)
4. Kramer CM, Rogers WJ Jr., Mankad S, Theobald TM, Pakstis DL, Yu YL. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 2000;36: 1835-40.
5. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 2001;103:871-6. (Pubitemid 32163887)
6. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-23. (Pubitemid 32151298)
7. Kim RJ, Judd RM, Chen EL, FIeno DS, Parrish TB, Lima JA. Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. Circulation 1999;100:185-92. (Pubitemid 29330018)
8. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36: 1985-91.
9. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000;102: 1678-83.
10. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
11. Rochitte CE, Kim RJ, Hillenbrand HB, Chen EL, Lima JA. Microvascular integrity and the time course of myocardial sodium accumulation after acute infarction. Circ Res 2000;87: 648-55.
12. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-7. (Pubitemid 32830391)
13. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780-3. (Pubitemid 32550063)
14. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-8. (Pubitemid 32056497)
15. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004; 43:2253-9. (Pubitemid 38757594)
16. Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113: 1865-70. (Pubitemid 43739398)
17. Tilak GS, Hsu LY, Hoyt RF Jr., Arai AE, Aletra AH. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol 2008; 43:7-15.
18. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1581-7. (Pubitemid 351508364)
19. Carlsson M, Ubachs JF, Hedström E, Heiberg E, Jovinge S, Arheden H. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. J Am Coll Cardiol Img 2009;2:569-76.
20. Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert K. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. J Am Coll Cardiol Img 2009;2:825-31.
21. Berry C, Kellman P, Mancini C, et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging 2010;3:527-35.
22. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94: 3318-26. (Pubitemid 26427504)
23. Huber S, Muthupillai R, Cheong B, et al. Safety of gadoversetamide in patients with acute and chronic myocardial infarction. J Magn Reson Imaging 2008;28:1368-78.